MedTrace Logo

Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort

NCT00467467 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-05-30

No results posted yet for this study

Summary

To assess the impact of alfuzosin vs. placebo on ureteral stent discomfort, urinary symptoms and quality of life.

Conditions

  • Ureteral Stent Discomfort

Interventions

DRUG

Alfuzosin Hydrochloride

Sponsors & Collaborators

Principal Investigators

  • Manoj Monga, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00467467 on ClinicalTrials.gov